MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1177/03913988231214180

Медицинская библиотека · The International journal of artificial organs · 2023

Cardiogenic shock etiology and exit strategy impact survival in patients with Impella 5.5.

Sicke McKenzie, Modi Shan, Hong Yeahwa, Bashline Michael, Klass Wyatt, Horn Ed, Hansra Barinder S, Ramanan Raj, Fowler Jeffrey, Sumzin Nikita, Rivosecchi Ryan M, Chaudhary Rahul, Ziegler Luke A, Hess Nicholas R, Agrawal Nishant, Kaczorowski David J, Hickey Gavin W

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Despite historical differences in cardiogenic shock (CS) outcomes by etiology, outcomes by CS etiology have yet to be described in patients supported by temporary mechanical circulatory support (MCS) with Impella 5.5.

OBJECTIVES

This study aims to identify differences in survival and post-support destination for these patients in acute myocardial infarction (AMI) and acute decompensated heart failure (ADHF) CS at a high-volume, tertiary, transplant center.

METHODS

A retrospective review of patients who received Impella 5.5 at our center from November 2020 to June 2022 was conducted.

RESULTS

Sixty-seven patients underwent Impella 5.5 implantation for CS; 23 (34%) for AMI and 44 (66%) for ADHF. AMI patients presented with higher SCAI stage, pre-implant lactate, and rate of prior MCS devices, and fewer days from admission to implantation. Survival was lower for AMI patients at 30 days, 90 days, and discharge. No difference in time to all-cause mortality was found when excluding patients receiving transplant. There was no significant difference in complication rates between groups.

CONCLUSIONS

ADHF-CS patients with Impella 5.5 support have a significantly higher rate of survival than patients with AMI-CS. ADHF patients were successfully bridged to heart transplant more often than AMI patients, contributing to increased survival.

Для цитирования: Sicke McKenzie, Modi Shan, Hong Yeahwa, Bashline Michael, Klass Wyatt, Horn Ed, Hansra Barinder S, Ramanan Raj, Fowler Jeffrey, Sumzin Nikita, Rivosecchi Ryan M, Chaudhary Rahul, Ziegler Luke A, Hess Nicholas R, Agrawal Nishant, Kaczorowski David J, Hickey Gavin W. Cardiogenic shock etiology and exit strategy impact survival in patients with Impella 5.5.. The International journal of artificial organs. 2023. DOI: 10.1177/03913988231214180.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.